Literature DB >> 2892892

Interaction of L-prolyl-L-leucyl glycinamide with dopamine D2 receptor: evidence for modulation of agonist affinity states in bovine striatal membranes.

L K Srivastava1, S B Bajwa, R L Johnson, R K Mishra.   

Abstract

The role of the hypothalamic tripeptide L-prolyl-L-leucyl-glycinamide (PLG) in modulating the agonist binding to bovine striatal dopamine D2 receptor was investigated using a selective high-affinity agonist, n-propylnorapomorphine (NPA). PLG caused an enhancement in [3H]NPA binding in striatal membranes in a dose-dependent manner, the maximum effect being observed at 10(-7)-10(-6) M concentration of the tripeptide. The Scatchard analysis of [3H]NPA binding to membranes preincubated with 10(-6) M PLG revealed a significant increase in the affinity of the agonist binding sites. In contrast, there was no effect of PLG on the binding pattern of the antagonist [3H]spiroperidol. The antagonist versus agonist competition curves analyzed for agonist high- and low-affinity states of the receptor displayed an increase in the population and affinity of the high-affinity form of the receptor with PLG treatment. The low-affinity sites concomitantly decreased with relatively small change in the affinity for the agonists. Almost similar results were obtained when either NPA or apomorphine was used in the competition experiments. A partial antagonistic effect of PLG on 5'-guanylylimidodiphosphate [Gpp(NH)p]-induced inhibition of high-affinity agonist binding was also observed, as the ratio of high- to low-affinity forms of the receptor was significantly higher in the PLG-treated membranes compared to the controls. Direct [3H]NPA binding experiments demonstrated that PLG attenuated the Gpp(NH)p-induced inhibition of agonist binding by increasing the EC50 of the nucleotide (concentration that inhibits 50% of the specific binding). No effect of PLG on high-affinity [3H]NPA binding, however, could be observed when the striatal membranes were preincubated with Gpp(NH)p.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2892892     DOI: 10.1111/j.1471-4159.1988.tb03005.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  14 in total

1.  PAOPA, a potent analogue of Pro-Leu-glycinamide and allosteric modulator of the dopamine D2 receptor, prevents NMDA receptor antagonist (MK-801)-induced deficits in social interaction in the rat: implications for the treatment of negative symptoms in schizophrenia.

Authors:  Bailee Dyck; Kelly Guest; Christal Sookram; Dipannita Basu; Rodney Johnson; Ram K Mishra
Journal:  Schizophr Res       Date:  2010-10-30       Impact factor: 4.939

2.  Design and synthesis of photoaffinity-labeling ligands of the L-prolyl-L-leucylglycinamide binding site involved in the allosteric modulation of the dopamine receptor.

Authors:  Abigail Fisher; Amandeep Mann; Vaneeta Verma; Nancy Thomas; Ram K Mishra; Rodney L Johnson
Journal:  J Med Chem       Date:  2006-01-12       Impact factor: 7.446

3.  Allosteric modulation of the dopamine D2 receptor by Pro-Leu-Gly-NH2 peptidomimetics constrained in either a polyproline II helix or a type II beta-turn conformation.

Authors:  Bhooma Raghavan; Kevin J Skoblenick; Swapna Bhagwanth; Niran Argintaru; Ram K Mishra; Rodney L Johnson
Journal:  J Med Chem       Date:  2009-04-09       Impact factor: 7.446

Review 4.  Amide Bond Bioisosteres: Strategies, Synthesis, and Successes.

Authors:  Shikha Kumari; Angelica V Carmona; Amit K Tiwari; Paul C Trippier
Journal:  J Med Chem       Date:  2020-08-04       Impact factor: 7.446

5.  Effect of haloperidol on expression of dopamine D2 receptor mRNAs in rat brain.

Authors:  L K Srivastava; M A Morency; S B Bajwa; R K Mishra
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

6.  Specific binding of photoaffinity-labeling peptidomimetics of Pro-Leu-Gly-NH2 to the dopamine D2L receptor: evidence for the allosteric modulation of the dopamine receptor.

Authors:  Amandeep Mann; Vaneeta Verma; Dipannita Basu; Kevin J Skoblenick; Michael G R Beyaert; Abigail Fisher; Nancy Thomas; Rodney L Johnson; Ram K Mishra
Journal:  Eur J Pharmacol       Date:  2010-05-27       Impact factor: 4.432

7.  A neurochemical basis for the antipsychotic activity of loxapine: interactions with dopamine D1, D2, D4 and serotonin 5-HT2 receptor subtypes.

Authors:  A N Singh; C Barlas; S Singh; P Franks; R K Mishra
Journal:  J Psychiatry Neurosci       Date:  1996-01       Impact factor: 6.186

8.  Transformation of Pro-Leu-Gly-NH2 peptidomimetic positive allosteric modulators of the dopamine D2 receptor into negative modulators.

Authors:  Swapna Bhagwanth; Satyendra Mishra; Ritesh Daya; Jordan Mah; Ram K Mishra; Rodney L Johnson
Journal:  ACS Chem Neurosci       Date:  2012-01-13       Impact factor: 4.418

9.  Solubilization and reconstitution of dopamine D1 receptor from bovine striatal membranes: effects of agonist and antagonist pretreatment.

Authors:  L K Srivastava; G M Ross; S B Bajwa; R K Mishra
Journal:  Neurochem Res       Date:  1990-06       Impact factor: 3.996

10.  Allosteric modulation of the dopamine receptor by conformationally constrained type VI beta-turn peptidomimetics of Pro-Leu-Gly-NH2.

Authors:  Ashish P Vartak; Kevin Skoblenick; Nancy Thomas; Ram K Mishra; Rodney L Johnson
Journal:  J Med Chem       Date:  2007-12-01       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.